Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis
Author:
Affiliation:
1. Department of Cardiology; Erasmus Medical Center; Rotterdam The Netherlands
2. Department of Intensive Care; Erasmus Medical Center; Rotterdam The Netherlands
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Reference30 articles.
1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial;CIBIS-II Investigators and Committees;Lancet,1999
2. Effects of controlled-release metoprolol on total mortality, hospitalizations and well-being in patients with heart failure: the Metoprolol CR/XL randomized intervention trail in congestive heart failure (Merit/HF);Hjalmarson;JAMA,2000
3. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001
4. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of carvedilol prospective randomized cumulative survival (COPERNICUS) study;Packer;Circulation,2002
5. Effects of initiating carvedilol in patients with severe chronic heart failure (results from the COPERNICUS study);Krum;JAMA,2003
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion;Frontiers in Cardiovascular Medicine;2023-11-16
2. Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology;European Journal of Heart Failure;2023-03-10
3. Beta-blockers and Ambulatory Inotropic Therapy;Journal of Cardiac Failure;2022-08
4. Left ventricular remodelling and prognosis after discharge in new‐onset acute heart failure with reduced ejection fraction;ESC Heart Failure;2021-05-02
5. Practical fluorothiolation and difluorothiolation of alkenes using pyridine-HF and N-thiosuccinimides;Organic Chemistry Frontiers;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3